ArticleFrontiers in pharmacology2019

Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma.

Fatima Bilal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.